[Hot Stock] L&K Bio Rises Intraday on News of New Product Export to the US
![[Hot Stock] L&K Bio Rises Intraday on News of New Product Export to the US](http://www.asiae.co.kr/news/img_view.htm?img=2018060413371567135_1528087035.jpg)
[Asia Economy Reporter Ji Yeon-jin] L&K Bio announced yesterday that its new product ‘PassLock-TM,’ approved by the U.S. Food and Drug Administration (FDA) in March this year, has been exported to the United States for the first time through its newly established U.S. subsidiary, L&K Spine.
PassLock-TM is a posterior and posterolateral implant product with the highest frequency of procedures. Like the expandable spinal implant, the Expandable Cage, it allows height adjustment at various widths and angles up to 20 degrees.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
PassLock-TM minimizes the incision area during surgery, reducing risks such as excessive bleeding and infection. It helps patients return to daily life in a short time after surgery.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
